Diane 35
Generic: Cyproterone Acetate/Ethinyl Estradiolby Bayer Zydus Pharma

Select pack size
Similar medicines
View allAbout Diane 35
Diane 35 is a hormone tablet made for the Indian market by Bayer Zydus Pharma. Each tablet contains 2 mg of cyproterone acetate, an anti-androgen, and 35 micrograms (0.035 mg) of ethinylestradiol, an oestrogen. The "35" in the name is the ethinylestradiol dose in micrograms, not 35 mg of anything. It is the same combination of the same doses as Bayer's Dianette in the UK and Diane-35 in Canada and Australia. Regulators license the combination for moderate to severe acne and excess facial or body hair (hirsutism) caused by sensitivity to male hormones (androgens), in women of reproductive age; for acne, only after other treatments have failed. It also prevents pregnancy, but it is not licensed for contraception alone. We sell Diane 35 in packs of 21 tablets (one cycle) and 42 tablets (two cycles), from $0.75 a tablet in the larger pack.
This page covers who the licensed use is for, how to take it, the price per cycle, the side effects, the blood clot risk, who must not take it, and its legal status. Clinical facts come from the UK Dianette Summary of Product Characteristics (SmPC), the Canadian Diane-35 product monograph and the European Medicines Agency (EMA) reviews, listed at the end. The Indian pack itself has not been tested in a published trial.
Diane 35 at a glance
| Active ingredients | Cyproterone acetate 2 mg and ethinylestradiol 35 micrograms per tablet |
| Brand and maker | Diane 35, by Bayer Zydus Pharma, India |
| Licensed use (UK label) | Moderate to severe acne related to androgen sensitivity (with or without oily skin) and/or hirsutism, in women of reproductive age. For acne, only after creams or gels and antibiotic tablets have failed |
| Regulatory status | Not approved by the FDA; cyproterone acetate is not an approved medicine in the US. The same combination is licensed as Dianette in the UK (MHRA), Diane-35 ED in Australia (TGA) and Diane-35 in Canada (Health Canada). The Indian pack sold here is not one of those licensed products |
| Usual dose from the label | One tablet daily for 21 days, then 7 tablet-free days |
| Time to work | At least three months for symptoms to improve (UK label) |
| Packs | 21 tablets (one cycle) and 42 tablets (two cycles) |
| Price per tablet | $0.90 (21 pack) and $0.75 (42 pack), before shipping |
| Delivery | 7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149 |
Price per tablet and per cycle
Prices below are as of October 2026. The pack selector above always shows the current price.
| Pack | Price | Per tablet | Per 21-day cycle | Shipping | Per cycle with shipping |
|---|---|---|---|---|---|
| 21 tablets (1 cycle) | $18.90 | $0.90 | $18.90 | $25 | $43.90 |
| 42 tablets (2 cycles) | $31.50 | $0.75 | $15.75 | $25 | $28.25 |
Both packs are below the $149 free shipping level, so the flat $25 shipping fee adds a lot to a single pack. Treatment usually runs for months (see how long to take it below), so you will need several cycles. Ordering several packs in one order spreads the shipping, and an order of $149 or more ships free.
Ginette 35 by Cipla contains the same two ingredients at the same doses. As of October 2026 it costs $18 for 21 tablets ($0.86 a tablet) and $29 for 42 tablets ($0.69 a tablet, $14.50 a cycle), before shipping, so it is slightly cheaper than Diane 35.
Compared with Dianette and other markets
| Diane 35 (India) | Dianette and co-cyprindiol (UK) | |
|---|---|---|
| Cyproterone acetate per tablet | 2 mg | 2 mg |
| Ethinylestradiol per tablet | 35 micrograms | 35 micrograms |
| Maker | Bayer Zydus Pharma | Bayer plc (Dianette); several generic makers (co-cyprindiol) |
| Licensed by the MHRA | No | Yes, prescription only |
| Cost | $15.75 to $18.90 per cycle before shipping | NHS Drug Tariff price for generic co-cyprindiol: £8.65 for 63 tablets (three cycles), about £2.88 a cycle |
The Drug Tariff figure is what the NHS pays pharmacies for the generic, not a price you can buy at, but it shows that a UK prescription is the cheaper and licensed route. In the UK, Dianette and co-cyprindiol are prescription-only medicines, so a doctor or nurse decides whether you should take it. In the US, no cyproterone acetate medicine is FDA approved, so there is no US price to compare. US readers looking for a pill for acne should ask a doctor about FDA-approved combined pills that carry an acne indication.
Diane 35 is made by Bayer Zydus Pharma in India, but we have not found a published study that compares the Indian pack with Dianette. Treat it as the same dose, not as proof of the same product.
What Diane 35 is used for
The UK label (SmPC 4.1) licenses cyproterone acetate 2 mg with ethinylestradiol 35 micrograms for:
- moderate to severe acne related to androgen sensitivity, with or without seborrhoea (oily skin)
- hirsutism (excess hair growth in a male pattern)
in women of reproductive age. For acne, it "should only be used after topical therapy or systemic antibiotic treatments have failed". The EMA set this wording for all of Europe in 2013, after reviewing the blood clot risk, and said the medicine should be used "solely" for these conditions. The Canadian label is narrower: severe acne with signs of androgen excess, including seborrhoea and mild hirsutism, when acne has not responded to topical treatment and oral antibiotics. The Australian label covers "signs of androgenisation in women, such as severe acne (involving inflammation or nodularity or risk of scarring) where prolonged oral antibiotics or local treatment alone has not been successful, or idiopathic hirsutism of mild to moderate degree".
It is not licensed as a contraceptive on its own. It does stop ovulation, so it protects against pregnancy when taken correctly, but the UK label says it "is not recommended in women solely for contraception" (5.1), and the Canadian label says it "should not be prescribed for the purpose of contraception alone". For contraception alone, a pill with a lower blood clot risk is the usual choice.
PCOS. Polycystic ovary syndrome often causes the acne and hirsutism this medicine is licensed for, and doctors may prescribe it for those symptoms in women with PCOS. It is not licensed to treat PCOS itself, and the UK label warns that its users are likely to include women with a higher underlying cardiovascular risk, such as that linked with PCOS (4.4). The EMA advised women taking it for other conditions to book a non-urgent appointment with their doctor to review their treatment. Our guide to metformin for PCOS covers another treatment doctors use.
How to take Diane 35
- Start the first strip on the first day of your period (day 1 of your cycle).
- Take one tablet a day, at about the same time, for 21 days.
- Then have 7 tablet-free days. A withdrawal bleed usually comes in this week.
- Start the next strip after the 7 tablet-free days.
- Do not take any other hormonal contraceptive at the same time (UK label 4.1 and 4.3): Diane 35 already prevents pregnancy, and the label says a second one would give an excessive dose of hormones (UK 4.2).
- If your bleed does not come in the tablet-free week, the label says pregnancy must be ruled out before the next strip.
Missed or late tablet. The UK Dianette label gives a 12-hour window (4.2). If a tablet is less than 12 hours late, take it as soon as you remember and protection is maintained. If it is more than 12 hours late, take the most recent missed tablet, leave out any earlier missed ones, and use condoms or another barrier method for the next 7 days. If this happens in the last 7 tablets of a strip, start the next strip without the tablet-free break. Follow this 12-hour rule from the Dianette label, even if guidance for other pills you have used differs. Our general missed pill guide covers other pills; for Diane 35 the label's 12-hour rule applies.
Vomiting or diarrhoea can stop the tablet being absorbed. Keep taking the tablets and use condoms or another barrier method during the illness and for 7 days after (4.2).
How long to take it. The UK label says it takes at least three months for symptoms to improve and that a doctor should check periodically whether treatment is still needed. The Canadian label adds that it "should be discontinued 3 to 4 cycles after signs have completely resolved". If acne or hair growth comes back later, a doctor can restart it, but the blood clot risk is highest again in the first year after a break of a month or more.
Medicines that interact with Diane 35
- Hepatitis C medicines: the UK label (4.3) contraindicates it with ombitasvir/paritaprevir/ritonavir and dasabuvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir. Liver enzyme (ALT) rises were seen in women on ethinylestradiol. Switch to a progestogen-only or non-hormonal method before starting these; Diane 35 can be restarted 2 weeks after the course ends (4.5).
- Enzyme inducers can make it less effective and cause breakthrough bleeding (4.5). The UK label names barbiturates, primidone, phenytoin, carbamazepine, oxcarbazepine, topiramate, griseofulvin, rifampicin, St John's wort, ritonavir, nelfinavir and nevirapine. On a short course, use condoms or another barrier method as well during treatment and for 28 days after. For long-term treatment with these medicines, the label says another method of contraception should be used.
- Other hormonal contraceptives: contraindicated together (4.3).
- Lamotrigine levels may fall, and ciclosporin levels may rise (4.5).
- Etoricoxib 60 to 120 mg a day raised ethinylestradiol levels 1.4 to 1.6 fold (4.5).
Tell your doctor about every medicine and herbal product you take before starting.
Side effects
The UK label (4.8) lists the most common side effects, in 1% or more of users, as nausea, abdominal pain, weight gain, headache, low or changed mood, and breast pain or tenderness.
| How often (UK label 4.8) | Side effects |
|---|---|
| Common (1 in 100 to 1 in 10) | Nausea, abdominal pain, weight gain, headache, depressed mood, mood changes, breast pain, breast tenderness |
| Uncommon (1 in 1,000 to 1 in 100) | Vomiting, diarrhoea, fluid retention, migraine, lower sex drive, breast enlargement, rash, hives |
| Rare (1 in 10,000 to 1 in 1,000) | Contact lens intolerance, allergic reaction, weight loss, higher sex drive, vaginal or breast discharge, erythema nodosum, erythema multiforme, blood clots (thromboembolism) |
| Reported after marketing (frequency not known) | Lighter periods, spotting, breakthrough bleeding, missed bleeds, no periods after stopping, darker skin patches (chloasma), higher blood pressure, raised triglycerides, liver function changes, worse angioedema, worsening of chorea, Crohn's disease or ulcerative colitis |
Mood. The label says depressed mood and depression are well-known effects of hormonal contraceptives, that "Depression can be serious and is a well-known risk factor for suicidal behaviour and suicide", and that women should contact their doctor about mood changes, including soon after starting (4.4).
Bleeding. Irregular spotting is common in the first months; the label says it is only meaningful to assess after about three cycles.
Blood clot risk
This is the main safety issue with Diane 35, and the reason for the 2013 European review. The UK label (4.4) says:
- it carries an increased risk of venous thromboembolism (VTE, clots in the leg veins or lungs) compared with no use;
- the risk is highest in the first year of use, or when restarting or switching after a break of at least a month;
- VTE "can be fatal in 1-2% of cases";
- studies show the VTE risk is 1.5 to 2 times higher than with pills containing levonorgestrel, and may be similar to pills containing desogestrel, gestodene or drospirenone.
The UK label gives these relative figures but no rate per 10,000 women. The Canadian monograph gives absolute figures:
| Group (Canadian monograph, Warnings, Hematologic) | Venous clots per 10,000 women a year |
|---|---|
| Women not pregnant and not on a combined hormone product | About 4.4 |
| Diane-35 users, published literature (non-fatal VTE) | 1.2 to 9.9 |
| Users of low-dose combined pills in a large cohort study | About 8 to 10 |
| Pregnant or postpartum women | 20 to 30 |
The risk also rises with age, smoking, obesity (BMI over 30), a parent or sibling who had a clot young, and long immobility or major surgery. The label says to stop at least four weeks before planned major surgery and not to restart until two weeks after you are fully mobile. Arterial clots (heart attack, stroke) are also linked with hormonal contraceptives. Our guide to birth control pills and blood clots explains how the risk differs between pill types.
When to get urgent help
Stop taking Diane 35 and get emergency help for any sign of a clot or stroke listed in the UK label (4.4):
- pain or swelling in one leg, especially the calf
- sudden severe chest pain, which may spread to the left arm, sudden breathlessness, or sudden coughing
- any unusual, severe or long-lasting headache, or a first or worsening migraine
- sudden partial or complete loss of vision, double vision, slurred speech, vertigo, or collapse with or without a seizure
- sudden weakness or numbness of one side or one part of the body
- severe pain in the upper abdomen
Also stop and see a doctor promptly for yellowing of the skin or eyes, itching all over, a big rise in blood pressure, or severe depression or thoughts of self-harm. Get emergency help for swelling of the lips, tongue or throat, trouble breathing or swallowing, rash, hives or blistering, which can be signs of a serious allergic reaction. Tell the emergency staff that you take cyproterone acetate with ethinylestradiol, how much and since when.
An overdose may cause nausea, vomiting and withdrawal bleeding (4.9). If a child swallows tablets, seek medical advice.
Who should not take Diane 35
Never take it if (UK label 4.3 contraindications) you:
- use another hormonal contraceptive
- have or have had a blood clot in a vein (deep vein thrombosis, pulmonary embolism) or an artery (for example a heart attack), or warning conditions such as angina or a transient ischaemic attack
- have had a stroke
- have a severe risk factor, or several risk factors, for clots, such as diabetes with blood vessel problems, severe high blood pressure or severe abnormal blood fats
- have an inherited or acquired clotting tendency, such as APC resistance, antithrombin III, protein C or protein S deficiency, hyperhomocysteinaemia or antiphospholipid antibodies
- have a history of migraine with focal neurological symptoms (often called migraine with aura)
- have or have had severe liver disease, such as active viral hepatitis or severe cirrhosis, until liver tests are back to normal
- have or have had a liver tumour, benign or malignant
- have or have had breast cancer
- have or have had a meningioma (see below)
- are or may be pregnant, or are breastfeeding
- are allergic to cyproterone acetate, ethinylestradiol or any ingredient of the tablet
- take the hepatitis C medicines listed above
The Canadian label adds undiagnosed vaginal bleeding, known or suspected oestrogen-dependent cancer, history of cholestatic jaundice, eye disease from blood vessel problems with loss of vision, and otosclerosis that worsened in pregnancy. Both labels say it is not for use after the menopause, and the UK label says it is not for use in men (4.3).
Smoking. The UK label says women over 35 "should be strongly advised not to smoke if they wish to use Dianette". The Canadian label says "Women who use this medication should not smoke", and that after age 35 such combinations should be considered only in exceptional circumstances.
Talk to a doctor first. The UK label (4.4) says these need strict medical supervision: diabetes with mild blood vessel disease, controlled high blood pressure, porphyria, depression, obesity, migraine, heart disease and chloasma. It also says lupus, inflammatory bowel disease, sickle cell disease, epilepsy, hereditary angioedema and high triglycerides may worsen or raise risks. The UK tablet contains lactose and sucrose; check the leaflet in your pack if you have a sugar intolerance.
Meningioma. Meningioma is a usually non-cancerous tumour of the membranes around the brain. In 2020 the EMA restricted cyproterone medicines with daily doses of 10 mg or more because of this risk. That restriction does not cover the 2 mg dose in Diane 35: the EMA said available data "do not indicate a risk" for 1 or 2 mg cyproterone combined with ethinylestradiol, but as a precaution they should not be used in people who have or have had a meningioma (the UK label makes this a contraindication, 4.3). The UK label (4.4) says meningiomas have been reported with cyproterone acetate "especially at high doses of 25mg and above and for prolonged time", and that if a meningioma is diagnosed, "any cyproterone containing treatment, including Dianette, must be stopped".
Pregnancy. Cyproterone acetate can feminise a male baby in animal studies, and the UK label contraindicates it in known or suspected pregnancy (4.3, 4.6). Rule out pregnancy before starting.
Prescription and legal status
- US: no medicine containing cyproterone acetate is approved by the FDA. The FDA says personal importation of unapproved medicines is illegal in most circumstances.
- UK: Dianette (Bayer plc) and generic co-cyprindiol are licensed by the MHRA as prescription-only medicines. The Indian Diane 35 pack is not authorised in the UK.
- Australia: Diane-35 ED is on the ARTG and is Schedule 4, prescription only. We found no ARTG listing for the Indian pack.
- Canada: Diane-35 (Bayer, DIN 02233542) and Cyestra-35 are listed in Health Canada's Drug Product Database as prescription medicines. We found no DIN for the Indian pack.
- India: PharmEasy lists Diane 35 as prescription required.
This is a medicine that needs a doctor's assessment: the licensed use depends on a diagnosis and on ruling out clot risk factors. See a doctor before you take it, and check the rules where you live.
Buying genuine Diane 35
The MHRA warns that any medicine not authorised for sale in the UK can be unsafe or ineffective and that there is no way of knowing what is in it, and it advises UK buyers to use only UK-registered pharmacies. That warning covers the Indian Diane 35 pack, which is not authorised in the UK. When your order arrives, check that the strip names Bayer Zydus Pharma, cyproterone acetate 2 mg and ethinylestradiol 0.035 mg, 21 tablets, and shows a batch number and an expiry date. These checks cannot prove that tablets are genuine, because counterfeiters copy packaging. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.
Delivery
We ship Diane 35 to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days to most countries. Shipping costs a flat $25 on orders under $149 and is free from $149. Order your next cycles early so you do not run out between strips. See our shipping page and refund policy.
Related guides
Sources
- Dianette 2 mg/35 microgram tablets, Summary of Product Characteristics, Bayer plc, revised 13 February 2023, sections 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.8, 4.9 and 5.1. emc
- European Medicines Agency. Cyproterone and ethinylestradiol containing medicines, Article 107i referral: benefits of Diane 35 and its generics outweigh risks in certain patient groups (EMA/318380/2013; European Commission decision 25 July 2013). EMA
- European Medicines Agency. Cyproterone containing medicinal products, Article 31 referral: restrictions in use of cyproterone due to meningioma risk, 2020. EMA
- DIANE-35 Product Monograph, Bayer Inc., date of revision 16 March 2017: Indications, Contraindications, Warnings and Precautions (Hematologic), Dosage and Administration. Health Canada DPD
- Health Canada Drug Product Database: DIANE-35, DIN 02233542, status Marketed, schedule Prescription; CYESTRA-35, DIN 02290308. Health Canada
- Therapeutic Goods Administration. Cyproterone: products containing cyproterone with ethinyloestradiol, such as Diane-35, safety advisory, 30 May 2013. TGA
- healthdirect Australia. Diane-35 ED (ARTG data): indication and Schedule 4 status. healthdirect
- NHS Drug Tariff price for co-cyprindiol 2000 microgram/35 microgram tablets, 63 tablets (Part VIIIA Category A), via OpenPrescribing, checked October 2026. OpenPrescribing
- PharmEasy product listing: Diane 35 strip of 21 tablets, Bayer Zydus Pharma, cyproterone 2.0 mg and ethinylestradiol 0.035 mg, prescription required. PharmEasy
- MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
- US Food and Drug Administration. Personal Importation. FDA
This page is for information and is not medical advice. Diane 35 should be taken only after a doctor has confirmed the diagnosis and checked your blood clot risk.
Frequently asked questions
What is Diane 35?
Diane 35 is a tablet from India, made by Bayer Zydus Pharma, that contains cyproterone acetate 2 mg, an anti-androgen, and ethinylestradiol 35 micrograms, an oestrogen. The 35 in the name is the ethinylestradiol dose in micrograms. Regulators in the UK, Australia and Canada license this combination for acne and excess hair growth caused by sensitivity to male hormones, in women of reproductive age; for acne, only after other treatments have failed. It also prevents pregnancy, but it is not licensed for contraception alone.
Is Diane 35 the same as Dianette?
It contains the same two ingredients at the same doses as Dianette, which Bayer sells in the UK. The Indian Diane 35 pack is not licensed by the MHRA, and we have not found a published study comparing the two packs, so treat them as the same dose rather than as proof of the same product. In the UK, Dianette and generic co-cyprindiol are available on prescription.
How much does Diane 35 cost per cycle?
As of October 2026 the 21 tablet pack (one cycle) costs $18.90, or $0.90 a tablet, and the 42 tablet pack (two cycles) costs $31.50, which is $15.75 a cycle or $0.75 a tablet, before shipping. Shipping is $25 on orders under $149 and free from $149, so ordering several cycles at once costs less per cycle. Ginette 35 by Cipla has the same ingredients and is slightly cheaper.
How do I take Diane 35?
Take one tablet a day for 21 days, starting on the first day of your period, then have 7 tablet-free days before starting the next strip. Do not take any other hormonal contraceptive with it. If a tablet is more than 12 hours late, the UK label says to take the most recent missed tablet and use condoms or another barrier method for the next 7 days.
Can I take Diane 35 just for contraception?
It does prevent pregnancy when taken correctly, but it is not licensed for contraception alone. The UK label says it is not recommended solely for contraception, and the Canadian label says it should not be prescribed for that purpose. The EMA restricted its use in 2013 because of its blood clot risk. For contraception alone, ask a doctor about a pill with a lower clot risk.
Is Diane 35 a treatment for PCOS?
It is not licensed to treat polycystic ovary syndrome itself. It is licensed for androgen-related acne and hirsutism, which are common in PCOS, and doctors may prescribe it for those symptoms. The UK label warns that women with PCOS may have a higher underlying cardiovascular risk, so the decision needs a doctor's assessment.
How long does Diane 35 take to work, and how long should I take it?
The UK label says it takes at least three months for symptoms to improve, and a doctor should check periodically whether you still need it. The Canadian label says it should be stopped 3 to 4 cycles after the signs have completely resolved. If symptoms return, a doctor may restart it, but the blood clot risk is highest again in the first year after a break of a month or more.
What are the side effects of Diane 35?
The UK label lists nausea, abdominal pain, weight gain, headache, low or changed mood, and breast pain or tenderness as common, affecting 1% or more of users. Spotting between periods is common in the first months. The most serious risk is a blood clot: the label says the risk of clots in the veins is 1.5 to 2 times higher than with pills containing levonorgestrel. Get emergency help for leg pain or swelling, chest pain, sudden breathlessness, or sudden problems with vision, speech or movement.
Who should not take Diane 35?
The UK label says never take it if you use another hormonal contraceptive, have had a blood clot, heart attack or stroke, have an inherited clotting disorder, have migraine with focal neurological symptoms, have severe liver disease or a liver tumour, have had breast cancer or a meningioma, are pregnant or breastfeeding, or take certain hepatitis C medicines such as ombitasvir/paritaprevir/ritonavir and dasabuvir, glecaprevir/pibrentasvir, or sofosbuvir/velpatasvir/voxilaprevir. Women over 35 should be strongly advised not to smoke if they use it.
Do I need a prescription for Diane 35?
It is prescription only wherever this combination is licensed: Dianette and co-cyprindiol in the UK, Diane-35 ED in Australia (Schedule 4) and Diane-35 in Canada. Cyproterone acetate is not approved by the FDA, and the FDA says personal importation of unapproved medicines is illegal in most circumstances. PharmEasy lists Diane 35 as prescription required in India. See a doctor before you take it.
How long does delivery take?
Standard delivery takes 7 to 14 business days to the US, UK, Australia and Canada, in plain packaging with tracking. Shipping is a flat $25 on orders under $149 and free from $149. Order your next cycles early so you do not have a gap between strips.
Medical References
- 1.PubMed (NCBI) (PMID: 41288141) — 2025
- 2.DailyMed (U.S. National Library of Medicine)
- 3.PubMed (NCBI) (PMID: 11727179) — 2001
- 4.PubMed (NCBI) (PMID: 11702316) — 2000
- 5.PubMed (NCBI) (PMID: 8616979) — 1995
- 6.PubMed (NCBI) (PMID: 41384221) — 2025
- 7.PubMed (NCBI) (PMID: 12600226) — 2003
- 8.PubMed (NCBI) (PMID: 21237335) — 2011
- 9.PubMed (NCBI) (PMID: 1903104) — 1991
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Diane 35? Tell other buyers how it went.







